These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency. Demirbuğa A; Kaba O; Törün SH; Yıldız EP; Yücel E; Somer A Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):109-111. PubMed ID: 34142853 [TBL] [Abstract][Full Text] [Related]
3. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era. Summers NA; Kelley CF; Armstrong W; Marconi VC; Nguyen ML AIDS Res Hum Retroviruses; 2019 Jun; 35(6):544-552. PubMed ID: 30834775 [TBL] [Abstract][Full Text] [Related]
4. Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis? AlTahan AM; Berger T; AlOrainy IA; AlTahan H Am J Case Rep; 2019 Jan; 20():101-105. PubMed ID: 30674865 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia. Harel A; Horng S; Gustafson T; Ramineni A; Farber RS; Fabian M J Neurovirol; 2018 Oct; 24(5):652-655. PubMed ID: 29987583 [TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia. de Regt MJ; Murk JL; Schneider-Hohendorf T; Wattjes MP; Hoepelman AI; Arends JE JMM Case Rep; 2016 Aug; 3(4):e005053. PubMed ID: 28348775 [TBL] [Abstract][Full Text] [Related]
7. Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency. Misbah SA Clin Exp Immunol; 2017 Jun; 188(3):342-352. PubMed ID: 28245526 [TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CCR5 antagonist maraviroc: medicinal chemistry and clinical applications. Xu GG; Guo J; Wu Y Curr Top Med Chem; 2014; 14(13):1504-14. PubMed ID: 25159165 [TBL] [Abstract][Full Text] [Related]
10. Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy. Middel A; Arends JE; van Lelyveld SF; Otto S; Schuurman R; Frijns CJ; Tesselaar K; Hoepelman AI Neurology; 2015 Jul; 85(1):104-6. PubMed ID: 26041329 [No Abstract] [Full Text] [Related]
11. Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8(+) T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome. Martin-Blondel G; Bauer J; Uro-Coste E; Biotti D; Averseng-Peaureaux D; Fabre N; Dumas H; Bonneville F; Lassmann H; Marchou B; Liblau RS; Brassat D Acta Neuropathol; 2015 Mar; 129(3):463-5. PubMed ID: 25589222 [No Abstract] [Full Text] [Related]
12. High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc. Stork L; Brück W; Bar-Or A; Metz I Acta Neuropathol; 2015 Mar; 129(3):467-8. PubMed ID: 25604548 [No Abstract] [Full Text] [Related]
13. Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy. Shahani L; Shah M; Tavakoli-Tabasi S BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26063110 [TBL] [Abstract][Full Text] [Related]